电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant CTLA4 抗体

This anti-CTLA4 antibody is a Humanized 单克隆 antibody detecting CTLA4 in FACS, WB 和 ELISA. Suitable for 人.
Rockland
产品编号 ABIN7540550
Supplier Product No.: 400-001-mt1
发货至: 中国

Quick Overview for Recombinant CTLA4 抗体 (ABIN7540550)

抗原

See all CTLA4 抗体
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

抗体类型

Recombinant Antibody

片段

Fab fragment

适用

  • 147
  • 77
  • 45
  • 14
  • 3

宿主

  • 86
  • 80
  • 17
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
Humanized

克隆类型

  • 117
  • 72
  • 3
单克隆

标记

  • 104
  • 16
  • 13
  • 11
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CTLA4 antibody is un-conjugated

应用范围

  • 89
  • 89
  • 62
  • 57
  • 43
  • 36
  • 19
  • 13
  • 10
  • 7
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
Flow Cytometry (FACS), Western Blotting (WB), ELISA

克隆位点

Abz521
  • Supplier Product No.

    400-001-mt1

    Supplier

    Rockland

    原理

    Recombinant Anti-CTLA4 Fab Antibody

    交叉反应 (详细)

    The purity was estimated to be >95 % by SDS-PAGE analysis.

    纯化方法

    Humanized Recombinant CLTA4 Fab fragment was expressed in CHO cells.

    过滤

    Sterile filtered

    亚型

    IgG1
  • 应用备注

    ELISA_Dilution: User Optimized

    Flow_Cytometry_Dilution: User Optimized

    Western_Blot_Dilution: User Optimized

    说明

    Humanized Recombinant Anti-CTLA-4 Fab fragment Antibody is tested for use in Flow Cytometry, Western Blot, and ELISA. This antibody recognizes structured CTLA-4 and will work in western blot when the protein has not been denatured with DTT or bMe. Although not tested, this antibody could be useful in in IHC and in in-vivo and other cellular assays. Specific conditions for reactivity should be optimized by the end user.

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: 30 % Glycerol

    Preservative: None

    储存液

    Without preservative

    储存条件

    4 °C

    储存方法

    Store vial at 2-8° C. Dilute only prior to immediate use.

    有效期

    6 months
  • 抗原

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    别名

    CTLA4

    背景

    Cytotoxic T-Lymphocyte Associated Protein 4, Ipilimumab, Yervoy, recombinant Monoclonal CTLA4, RabMAb CTLA4, CTLA-4, CD152, Insulin-Dependent Diabetes Mellitus 12, Cytotoxic T-Lymphocyte Protein 4, Celiac Disease 3, GSE, CD, Ligand And Transmembrane Spliced, Cytotoxic T Lymphocyte Associated Antigen 4, Cytotoxic T Lymphocyte Associated Antigen 4 Short Spliced Form, Cytotoxic T-Lymphocyte-Associated Serine Esterase-4, Cytotoxic T-Lymphocyte-Associated Antigen 4, CD152 Isoform, CD152 Antigen, CELIAC3, IDDM12, ALPS5, GRD4,CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4) is also known as CD152 (Cluster of differentiation 152), is a protein receptor that functions as an immune checkpoint and downregulates immune responses. CTLA4 is constitutively expressed in regulatory T cells but only upregulated in conventional T cells after activation - a phenomenon which is particularly notable in cancers. It acts as an "off" switch when bound to CD80 or CD86 on the surface of antigen-presenting cells. CTLA4 is a member of the immunoglobulin superfamily. The protein contains an extracellular V domain, a transmembrane domain, and a cytoplasmic tail. Alternate splice variants, encoding different isoforms. CTLA4 is similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B7-1 and B7-2 respectively, on antigen-presenting cells. CTLA4 transmits an inhibitory signal to T cells, whereas CD28 transmits a stimulatory signal. Intracellular CTLA4 is also found in regulatory T cells and may be important to their function. T cell activation through the T cell receptor and CD28 leads to increased expression of CTLA-4, an inhibitory receptor for B7 Molecules. Fusion proteins of CTLA4 and antibodies (CTLA4-Ig) have been used in clinical trials for rheumatoid arthritis. This antibody is made from a humanized Fab fragment of anti-CTLA4, ipilimumab or Yervoy, the first FDA approved immune checkpoint blockade therapy for cancer treatment. Humanized Recombinant Anti-CTLA4 fragment Antibody is useful for researchers interested in cancer research, immunodeficiency, and autoimmune diseases.

    基因ID

    1493

    NCBI登录号

    NP_001032720

    UniProt

    P16410

    途径

    Cancer Immune Checkpoints
You are here:
Chat with us!